Actively Recruiting

Phase Not Applicable
Age: 16Years - 35Years
All Genders
Healthy Volunteers
NCT05866835

Validation of a Digitalised Intraoral Protection

Led by University Hospital, Bordeaux · Updated on 2025-08-08

60

Participants Needed

3

Research Sites

116 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Type III (custom-made) intra-oral protection (IOP) models represent 13% of IOP worn by amateur rugby club players in France. However, this model is recognized as the most effective when made in accordance with essential health and safety requirements. This observation is at the origin of a new approach that the investigators are proposing with the objective of removing the barriers to access to custom-made IOP. This research is based on the combination of new digital technologies, scanning and 3D printing, to develop a new generation of IOP. This project aims to show the interest of this new generation of "modified unimaxillary" IOP on the ventilation of the athletes and his/her comfort when he/she evolves with his IOP in place

CONDITIONS

Official Title

Validation of a Digitalised Intraoral Protection

Who Can Participate

Age: 16Years - 35Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects between the ages of 16 and 35
  • Subject affiliated to a social security system
  • Subject affiliated with the French Federation of Boxing or Rugby or Football
  • Subject having signed a consent form
  • For minors, legal guardians having signed the free and informed consent form
Not Eligible

You will not qualify if you...

  • Subjects with pathologies incompatible with the trial, including:
    • Recent infarction (wait 5 to 12 days depending on severity)
    • Threat syndrome (test after stabilization with at least 3 days without seizures)
    • Resting blood pressure over 200/120 mmHg
    • Uncompensated heart failure
    • Third-degree atrioventricular block
    • Myocarditis, pericarditis, endocarditis
    • Aortic dissection
    • Intracardiac tumor or thrombus
    • Deep venous thrombosis or pulmonary embolism
    • Aortic stenosis with lipothymia, syncope, or heart failure signs
    • Severe non-revascularized coronary artery disease
    • Pulmonary arterial hypertension (especially primary)
    • Severe rapid ventricular or supraventricular arrhythmias
  • Subject under B-mimetic drug treatment
  • Subject with decaying teeth
  • Subject under court protection
  • Subject participating in another research study
  • Subject who is pregnant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

CHU de Bordeaux

Bordeaux, France

Not Yet Recruiting

2

CREPS de Bordeaux

Bordeaux, France

Actively Recruiting

3

Institut national du sport, de l'expertise et de la performance (INSEP)

Paris, France

Not Yet Recruiting

Loading map...

Research Team

P

Philippe POISSON, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here